Get started
Author

Daniel A. Calarese

Printed covalent glycan array for ligand profiling of diverse glycan binding proteins
2004 · Ola Blixt, Steve Head, et al. · Proceedings of the National Academy of Sciences · 1,120
PDF
Antibody Domain Exchange Is an Immunological Solution to Carbohydrate Cluster Recognition
2003 · Daniel A. Calarese, Christopher N. Scanlan, et al. · Science · 789
Dissection of the carbohydrate specificity of the broadly neutralizing anti-HIV-1 antibody 2G12
2005 · Daniel A. Calarese, Hing-Ken Lee, et al. · Proceedings of the National Academy of Sciences · 293
Receptor Tyrosine Kinases, TYRO3, AXL, and MER, Demonstrate Distinct Patterns and Complex Regulation of Ligand-induced Activation
2014 · Wen-I Tsou, Khanh-Quynh N. Nguyen, et al. · Journal of Biological Chemistry · 243
Covalent Display of Oligosaccharide Arrays in Microtiter Plates
2004 · Marian C. Bryan, Fabio Fazio, et al. · Journal of the American Chemical Society · 174
Reactivity‐Based One‐Pot Synthesis of Oligomannoses: Defining Antigens Recognized by 2G12, a Broadly Neutralizing Anti‐HIV‐1 Antibody
2004 · Hing‐Ken Lee, Christopher N. Scanlan, et al. · Angewandte Chemie International Edition · 125
PDF
Overexpression of MERTK Receptor Tyrosine Kinase in Epithelial Cancer Cells Drives Efferocytosis in a Gain-of-Function Capacity
2014 · Khanh-Quynh N. Nguyen, Wen-I Tsou, et al. · Journal of Biological Chemistry · 103
PDF
Discovery of STRO-002, a Novel Homogeneous ADC Targeting Folate Receptor Alpha, for the Treatment of Ovarian and Endometrial Cancers
2022 · Xiaofan Li, Sihong Zhou, et al. · Molecular Cancer Therapeutics · 76
PDF
The Carbohydrate Epitope of the Neutralizing Anti-HIV-1 Antibody 2G12
2003 · Christopher N. Scanlan, Ralph Pantophlet, et al. · Advances in experimental medicine and biology · 63
Homogeneous antibody-drug conjugates with dual payloads: potential, methods and considerations
2025 · Miao Wen, Abigail Yu, et al. · mAbs · 54
Inhibition of Zinc-Dependent Histone Deacetylases with a Chemically Triggered Electrophile
2016 · Zarko V. Boskovic, Melissa M. Kemp, et al. · ACS Chemical Biology · 35
A peptide inhibitor of HIV‐1 neutralizing antibody 2G12 is not a structural mimic of the natural carbohydrate epitope on gp120
2008 · Alfredo Menendez, Daniel A. Calarese, et al. · The FASEB Journal · 33
Reactivity‐Based One‐Pot Synthesis of Oligomannoses: Defining Antigens Recognized by 2G12, a Broadly Neutralizing Anti‐HIV‐1 Antibody
2004 · Hing‐Ken Lee, Christopher N. Scanlan, et al. · Angewandte Chemie · 17
Toward a Carbohydrate-Based HIV-1 Vaccine
2012 · Leopold Kong, Jean-Philippe Julien, et al. · ACS symposium series · 6
Abstract 2870: Enhancing Topo1i ADC efficacy: development of homogeneous dual-payload ADCs combining Topo1i with microtubule inhibitors or PARP inhibitors
2025 · Gang Yin, Daniel Calarese, et al. · Cancer Research · 4
Antibody Recognition of a Carbohydrate Epitope: A Template for HIV Vaccine Design
2005 · Chris Scanlan, Daniel Calarese, et al. · Advances in experimental medicine and biology · 4
Toward a Carbohydrate-Based HIV-1 Vaccine
2006 · Daniel Calarese, Christopher Scanlan, et al. · ACS symposium series · 3
Abstract 1685: The HER2-targeting dual-payload antibody-drug conjugate combining a topoisomerase I inhibitor and a microtubule inhibitor demonstrates superior efficacy and overcomes resistance to single-payload ADCs in xenograft models
2026 · Angela Matcham, Robert Yuan, et al. · Cancer Research · 1
Abstract 4436: Sutro’s site-specific dual-payload ADCs combining TOPO1i and DNA damage response inhibitors to enhance efficacy, overcome resistance, and improve safety
2026 · Krishna Bajjuri, Robert Yuan, et al. · Cancer Research · 1
Abstract 1572: Preclinical activity and safety of STRO-004, a novel ADC targeting tissue factor for solid tumors
2025 · Andrew McGeehan, Helena Kiefel, et al. · Cancer Research · 1
Data from Discovery of STRO-002, a Novel Homogeneous ADC Targeting Folate Receptor Alpha, for the Treatment of Ovarian and Endometrial Cancers
2023 · Xiaofan Li, Sihong Zhou, et al. · 1
1191 STRO-003 is a novel ROR1-targeted ADC for breast and lung cancer
2022 · Alice Yam, Jeff Hanson, et al. · Journal for ImmunoTherapy of Cancer · 1
PDF
1103 Half-life extended, conditionally active IFNa prodrug induces tumor-selective activation and potent antitumor response
2022 · Alice Yam, Kshama Doshi, et al. · Journal for ImmunoTherapy of Cancer · 1
PDF
Abstract 1695: Preclinical characterization of STRO-227: A PTK7-targeting dual-payload ADC with topoisomerase 1 and tubulin inhibitors
2026 · Daniel Calarese, Kshama Doshi, et al. · Cancer Research
Abstract 1713: STRO-006: An Integrin beta-6-targeting ADC demonstrates favorable safety profile and potent antitumor activity in preclinical solid tumors
2026 · Kshama A. Doshi, Stephanie Armstrong, et al. · Cancer Research
Works count: 43
Citation count: 3,148
H-index: 13
I10-index: 13
Year
Topic
Type